Iodine-Catalyzed Regioselective Sulfenylation of 4H-Pyrido[1,2-a]pyrimidin-4-ones with Sulfonyl Hydrazides
作者:Shaohua Wang、Wenjie Liu、Zhihao Cai、Ziying Li、Jianwen Liu、Anda Wang
DOI:10.1055/s-0036-1588549
日期:2018.1
A simple and efficient method for direct sulfenylation of 4H-pyrido[1,2-a]pyrimidin-4-ones with sulfonyl hydrazides has been developed. The transformation is catalyzed by iodine under metal-free conditions with high regioselectivity and good functional-group tolerance.
Regioselective C3 Alkenylation of 4 <i>H</i>-pyrido[1,2-<i>a</i>]pyrimidin-4-ones via Palladium-Catalyzed CH Activation
作者:Wenjie Liu、Shaohua Wang、Qi Zhang、Jingwen Yu、Jiahe Li、Zhiwei Xie、Hua Cao
DOI:10.1002/asia.201402455
日期:2014.9
A general and efficient palladium‐catalyzed direct C3alkenylation of 4H‐pyrido[1,2‐a]pyrimidin‐4‐ones using AgOAc/O2 as the oxidant has been developed. A variety of 4H‐pyrido[1,2‐a]pyrimidin‐4‐ones were successfully coupled with acrylate esters, styrenes, methylvinylketone, and acrylamide in moderate to excellent yields. The reaction exhibited complete regio‐ and stereoselectivity. This transformation
已经开发了一种以AgOAc / O 2为氧化剂的4 H-吡啶并[1,2 - a ]嘧啶-4-酮的普通钯催化的直接C3烯基化反应。各种4 H-吡啶并[1,2 - a ]嘧啶-4-酮已成功与丙烯酸酯,苯乙烯,甲基乙烯基酮和丙烯酰胺偶联,产率中等至优异。该反应显示出完全的区域选择性和立体选择性。该转化提供了一种有吸引力的新方法,可对4个H-吡啶并[1,2- a ]嘧啶-4-酮进行功能化。
THIENODIAZEPINE DERIVATIVES AND APPLICATION THEREOF
The present invention relates to a class of thienodiazepine derivatives and an application thereof in the preparation of a drug for the treatment of diseases associated with bromodomain and extra-terminal (BET) Bromodomain inhibitors. Specifically, the present invention relates to compounds represented by formulas (I) and (II), as well as pharmaceutically acceptable salts thereof.
The present invention relates to a class of thienodiazepine derivatives and an application thereof in the preparation of a drug for the treatment of diseases associated with bromodomain and extra-terminal (BET) Bromodomain inhibitors. Specifically, the present invention relates to compounds represented by formulas (I) and (II), as well as pharmaceutically acceptable salts thereof.